These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8034980)

  • 1. Inhibition of class II MHC-peptide complex formation by protease inhibitors.
    Liang MN; Witt SN; McConnell HM
    J Immunol Methods; 1994 Jul; 173(1):127-31. PubMed ID: 8034980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
    Muno D; Kominami E; Mizuochi T
    FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and dissociation of short-lived class II MHC-peptide complexes.
    Witt SN; McConnell HM
    Biochemistry; 1994 Feb; 33(7):1861-8. PubMed ID: 8110789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation.
    Hart M; Beeson C
    J Med Chem; 2001 Oct; 44(22):3700-9. PubMed ID: 11606135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions of the subunits of the class II major histocompatibility complex molecule IAd.
    Tampé R; Tyvoll D; McConnell HM
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10667-70. PubMed ID: 1961734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.
    Nag B; Passmore D; Deshpande SV; Clark BR
    J Immunol; 1992 Jan; 148(2):369-72. PubMed ID: 1370312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers.
    McFarland BJ; Sant AJ; Lybrand TP; Beeson C
    Biochemistry; 1999 Dec; 38(50):16663-70. PubMed ID: 10600129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
    Bangia N; Watts TH
    Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and specificity of peptide-MHC class II complex displacement reactions.
    de Kroon AI; McConnell HM
    J Immunol; 1994 Jan; 152(2):609-19. PubMed ID: 8283041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad.
    Tampé R; McConnell HM
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4661-5. PubMed ID: 2052549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC.
    Liang MN; Beeson C; Mason K; McConnell HM
    Int Immunol; 1995 Sep; 7(9):1397-404. PubMed ID: 7495747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of peptide antigen presentation by a second peptide.
    de Kroon AI; McConnell HM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8797-801. PubMed ID: 8105466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of truncated peptides to the MHC molecule IA (d).
    Dornmair K; Clark BR; McConnell HM
    FEBS Lett; 1991 Dec; 294(3):244-6. PubMed ID: 1661686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of the binding of MHC class II-derived peptides to MHC class II.
    Feili-Hariri M; Kao H; Mietzner TA; Morel PA
    Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
    Sanderson S; Frauwirth K; Shastri N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7217-21. PubMed ID: 7638170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the accessibility of peptide in an MHC class II protein--foreign peptide complex.
    Gariépy J; Watts TH
    Int Immunol; 1991 Mar; 3(3):279-84. PubMed ID: 2049342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.
    Lamont AG; Powell MF; Colón SM; Miles C; Grey HM; Sette A
    J Immunol; 1990 Apr; 144(7):2493-8. PubMed ID: 2319129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.